Advertisement

Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma

      Abstract

      Objective

      To emulate two target clinical trials of radical nephrectomy (RN) with lymph node dissection (LND) vs radical nephrectomy alone.

      Methods

      Using the National Cancer Database, we separately emulated an index trial of patients with cT1-3cN0cM0 renal cell carcinoma (RCC), designed to resemble EORTC 30881 (“index trial emulation”), and a hypothetical trial of patients at increased risk for lymph node metastases with cT1-4cN0-1cM0 RCC (“high-risk trial emulation”). A propensity score for LND was estimated using preoperative features (Model 1) or preoperative and pathologic features (Model 2). The associations of LND with overall survival (OS) were estimated using Cox regression with stabilized inverse probability weights.

      Results

      A total of 67,388 patients were included in the index trial emulation. Median follow-up was 49.2 (interquartile range 27.2-74.3) months. LND was not associated with improved OS when adjusting using either Model 1 (hazard ratio [HR] 1.26; 95% confidence interval [CI] 1.20-1.33; P <.0001) or Model 2 (HR 1.13; 95% CI 1.07-1.20; P <.0001). A total of 69,477 patients were included in the high-risk trial emulation. Median follow-up was 48.6 (interquartile range 26.6-73.8) months. LND was not associated with improved OS when adjusting using either Model 1 (HR 1.24; 95% CI 1.18-1.30; P <.0001) or Model 2 (HR 1.09; 95% CI 1.04-1.16; P = .001). In sensitivity analyses, LND was not associated with improved OS across cN stage, pT stage, tumor grade, histologic subtype, or probability of pN1 disease.

      Conclusion

      In observational analyses, that emulate target trials representing EORTC 30881 and a trial of LND in high-risk RCC, LND was not associated with improved OS.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Robson CJ
        Radical nephrectomy for renal cell carcinoma.
        J Urol. 1963; 89: 37-42
        • Blom JH
        • van Poppel H
        • Marechal JM
        • et al.
        Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.
        Eur Urol. 2009; 55: 28-34
        • Pantuck AJ
        • Zisman A
        • Dorey F
        • et al.
        Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
        J Urol. 2003; 169: 2076-2083
        • Schafhauser W
        • Ebert A
        • Brod J
        • Petsch S
        • Schrott KM
        Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy.
        Anticancer Res. 1999; 19: 1573-1578
        • Herrlinger A
        • Schrott KM
        • Schott G
        • Sigel A
        What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma.
        J Urol. 1991; 146: 1224-1227
        • Feuerstein MA
        • Kent M
        • Bazzi WM
        • Bernstein M
        • Russo P
        Analysis of lymph node dissection in patients with >/=7-cm renal tumors.
        World J Urol. 2014; 32: 1531-1536
        • Feuerstein MA
        • Kent M
        • Bernstein M
        • Russo P
        Lymph node dissection during cytoreductive nephrectomy: a retrospective analysis.
        Int J Urol. 2014; 21: 874-879
        • Bhindi B
        • Wallis CJD
        • Boorjian SA
        • et al.
        The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis.
        BJU Int. 2018; 121: 684-698
        • Gershman B
        • Thompson R
        • Moreira D
        • et al.
        Radical nephrectomy with or without lymph node dissection for nonmetastatic renal cell carcinoma: a propensity score-based analysis.
        Eur Urol. 2016; https://doi.org/10.1016/j.eururo.2016.09.019
        • Gershman B
        • Thompson RH
        • Moreira DM
        • et al.
        Lymph node dissection is not associated with improved survival among patients undergoing cytoreductive nephrectomy for metastatic renal cell carcinoma: a propensity score based analysis.
        J Urol. 2017; 197: 574-579
        • Margulis V
        • Wood CG
        The role of lymph node dissection in renal cell carcinoma: the pendulum swings back.
        Cancer J. 2008; 14: 308-314
        • Gershman B
        • Guo DP
        • Dahabreh IJ
        Using observational data for personalized medicine when clinical trial evidence is limited.
        Fertil Steril. 2018; 109: 946-951
        • Hernan MA
        • Robins JM
        Using big data to emulate a target trial when a randomized trial is not available.
        Am J Epidemiol. 2016; 183: 758-764
        • D'Agostino Jr, RB
        Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.
        Stat Med. 1998; 17: 2265-2281
        • Harrell Jr, FE
        Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis.
        Springer, New York2001
        • Kim SP
        • Campbell SC
        • Gill I
        • et al.
        Collaborative review of risk benefit trade-offs between partial and radical nephrectomy in the management of anatomically complex renal masses.
        Eur Urol. 2017; 72: 64-75
        • Gershman B
        • Thompson RH
        • Boorjian SA
        • et al.
        Radical versus partial nephrectomy for cT1 renal cell carcinoma.
        Eur Urol. 2018; 74: 825-832
        • Hernan MA
        • Alonso A
        • Logan R
        • et al.
        Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.
        Epidemiology. 2008; 19: 766-779
        • Ristau BT
        • Manola J
        • Haas NB
        • et al.
        Retroperitoneal lymphadenectomy in high-risk non-metastatic renal cell carcinoma: an analysis of the ASSURE (ECOG-ACRIN 2805) adjuvant trial.
        J Urol. 2018; 199: 53-59
        • Bekema HJ
        • MacLennan S
        • Imamura M
        • et al.
        Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma.
        Eur Urol. 2013; 64: 799-810
        • Gershman B
        • Thompson RH
        • Boorjian SA
        • et al.
        Radical nephrectomy with or without lymph node dissection for high risk nonmetastatic renal cell carcinoma: a multi-institutional analysis.
        J Urol. 2018; 199: 1143-1148